AXIM Biotechnologies's basic earnings per share (Basic EPS) for the
three
months ended in Mar. 2025 was $-0.00.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.01.
AXIM Biotechnologies's EPS without NRI for the
three
months ended in Mar. 2025 was $-0.00.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.01.
During the past 3 years, the average EPS without NRIGrowth Rate was 23.90% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 22.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -7.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, AXIM Biotechnologies's highest 3-Year average EPS without NRI Growth Rate was 24.10% per year. The lowest was -300.00% per year. And the median was 16.70% per year.
AXIM Biotechnologies EPS (Basic) Historical Data
The historical data trend for AXIM Biotechnologies's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
AXIM Biotechnologies's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
AXIM Biotechnologies EPS (Basic) Related Terms
Thank you for viewing the detailed overview of AXIM Biotechnologies's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
AXIM Biotechnologies Inc is a developer of diagnostic healthcare solutions serving to enhance the health of people. It focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells, as well as for oncological indications.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AXIM has been successfully added to your 